Lauck Andrew bought 2,000 shares of Strata Critical Medical, Inc. at $5.00 for $10.0k on Nov 5, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$9,998Shares × reported price
Shares traded
2,000Class A common stock, $0.0001 par value per share
Price per share
$5.00Reported price. Read footnotes for ranges.
% of reported position traded
1.17%This security and ownership context
Holdings after
172,902Direct
Trade date
Nov 5, 2026Buy
Filed
Nov 9, 2026, 8:57 AM ET4-day reporting delay
Accession
0001628280-26-071913Code P · Transaction 395539
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 170,902 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

SRTA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
SRTA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −21%1w ago −21%1d ago −14%
Returns since7d −8.9%30d90d180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.